Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
iBio, Inc.
| Metric | iBio, Inc. IBIOOther |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $400,000 |
| Net income (latest) | −$18M |
| Operating margin | −4650.5% |
| Net margin | −4594.3% |
| Return on equity | −123.5% |
| Return on assets | −79.3% |
| Return on capital (ROCE) | −108.9% |
| Debt / equity | 0.56× |
| Revenue growth (YoY) | 77.8% |
| Altman Z″ (distress) | -49.20 |
| Accruals / assets | −13.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.